Curing hepatitis C could yield huge economic benefit

Sunday, May 17, 2015 - 18:00 in Health & Medicine

While a new generation of safer, more effective oral medications to treat hepatitis C patients may cost tens of thousands of dollars for a 12-week regiment, investing in these new therapies could generate savings estimated at more than $3.2 billion annually in the US and five European countries, according to a new study. These savings would have a significant economic impact on society.

Read the whole article on Science Daily

More from Science Daily

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net